Related Experiment Video
Updated: May 4, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
Teratology: general considerations and principles
1Birth Defects Research Laboratory, Department of Veterinary Anatomy and Public Health, Texas A&M University, College of Veterinary Medicine, College Station, Texas 77843-4458, USA.
Insights
Approximately 3-5% of US births have developmental defects, with 2-3% caused by teratogens. Understanding drug effects and dose-response is key to preventing these birth defects.
Area of Science:
- Teratology
- Developmental Toxicology
- Pharmacology
Background:
- Developmental defects affect 3-5% of US births.
- Teratogen-induced malformations account for 2-3% of these defects.
- Drug-induced abnormal development can manifest as death, malformation, growth retardation, or functional disorder.
Purpose of the Study:
- To review the factors influencing susceptibility to drug-induced malformations.
- To emphasize the importance of understanding drug-specific teratogenic effects.
- To highlight the preventability of teratogen-induced birth defects.
Main Methods:
- Literature review on teratology and drug-induced developmental abnormalities.
- Analysis of factors affecting teratogenic outcomes.
- Discussion of dose-response relationships in teratogenesis.
Main Results:
- Susceptibility to drug-induced malformations depends on conceptus genotype, developmental stage, drug mechanism, tissue access, and dose.
- Nearly all teratogen-induced birth defects are preventable.
Conclusions:
- Clear definition of dose-response relationships is crucial for preventing teratogen-induced birth defects.
- Preventive strategies should consider individual susceptibility factors.
- Further research into specific drug-teratogen interactions is warranted.
Abstract:
Approximately 3% to 5% of children born in the United States manifest developmental defects. Between 2% and 3% of these birth defects can be classified as teratogen-induced malformations, which result from environmental or iatrogenic exposures during pregnancy. The final manifestations of drug-induced abnormal development can be death, malformation, growth retardation, or functional disorder. In considering the potential teratogenic effects of drugs, it is important to remember that susceptibility to a drug-induced malformation depends on: (1) the genotype of the conceptus, (2) the developmental stage at which exposure occurs, (3) the mechanisms of action of the drug, (4) the access of the drug to developing tissues, and (5) the dose of the drug. Nearly all teratogen-induced birth defects are preventable if the dose-response relationship for teratogen exposure and the teratogenic activity of the drug can be clearly defined.
Related Concept Videos
Anatomical Terminology
Anatomical Positions
The body is upright, facing forward, and standing erect.
The feet are parallel and flat on the floor.
The arms are hanging by the...
Teratogenicity
Toxicity Testing in Animals

